Quick Answer
Enveric Biosciences, Inc. reported Earnings Per Share Diluted of $36.24 (loss) per share for the year ending 2025.
- Enveric Biosciences, Inc. showed an increase of +84.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2016 to 2025), Enveric Biosciences, Inc.'s Earnings Per Share Diluted has declined by 17,157.1%.
- Historical annual values: Fiscal year 2025: $36.24 (loss) per share | Fiscal year 2024: $228.48 (loss) per share | Fiscal year 2023: $121.29 (loss) per share | Fiscal year 2022: $13.00 (loss) per share | Fiscal year 2019: $2.83 (loss) per share | Fiscal year 2018: $20.47 (loss) per share | Fiscal year 2017: $0.75 (loss) per share | Fiscal year 2016: $0.21 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: